• Company
• JAKi Civinqo completes pricing negotiations for reimb in KOR
• by Eo, Yun-Ho Jun 22, 2023 05:40am

• Company
• Joint development & production of DM Combi with SK Chem & AZ
• by Kim, Jin-Gu Jun 21, 2023 10:06am

• Opinion
• [Reporter’s View] Closer look into Korea’s new drug access
• by Eo, Yun-Ho Jun 21, 2023 05:53am

• ‘Botulinum resistance lasts for at least 4 years’
• by Jung, Sae-Im Jun 21, 2023 05:52am

• Policy
• 85% of the public requests more coverage for severe diseases
• by Lee, Jeong-Hwan Jun 21, 2023 05:52am

• Company
• Camzyos, which prevents sudden cardiac death in young people
• by Jung, Sae-Im Jun 21, 2023 05:51am

• Company
• [two thousandth]Toxins accumulated in Soyul's body every day
• by Jung, Sae-Im Jun 21, 2023 05:50am

• Policy
• Mandatory benefit for Erleada impact?
• by Lee, Tak-Sun Jun 20, 2023 05:36am

• Policy
• Negotiations between Verquvo and Retevmo begin
• by Lee, Tak-Sun Jun 20, 2023 05:36am

• ‘Risk of resistance to BoNT-A may rise in the next 1-2 yrs'
• by Jung, Sae-Im Jun 20, 2023 05:35am